Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of [11C]MeDAS PET Agent in Humans
NCT04333290Phase 1Withdrawn
- Start
- Jul 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fluorine f 18 ara-g. Primary endpoints: Radiation dosimetry at 2 hours, Biodistribution analysis at 2 hours and 3 more. Planned start Jul 2024; status: withdrawn.
02
Drugs
fluorine f 18 ara-g
Beyond the preview
Go deeper on NCT04333290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04333290.